Target intelligence / Profile preview

Central analgesic pathways

Molecular classification
Other
01

Overview

Central analgesic pathways refer to the complex neural circuits within the brain and spinal cord responsible for the endogenous modulation and suppression of pain signals. A primary component is the descending inhibitory pathway, which originates in higher brain centers such as the periaqueductal gray (PAG) and the rostral ventromedial medulla (RVM), projecting down to the dorsal horn of the spinal cord (StatPearls, 2023). These pathways utilize various neurotransmitters, including endogenous opioids, serotonin, and norepinephrine, to attenuate the transmission of nociceptive information from peripheral nerves to the brain (Nature Reviews Neuroscience, 2009). Dysfunction in these pathways is a hallmark of chronic pain states, where a failure of endogenous inhibition or an increase in descending facilitation leads to hypersensitivity (Journal of Clinical Investigation, 2010). Pharmacological intervention often targets specific receptors within these pathways, such as opioid receptors or adrenergic receptors, to enhance inhibitory control and provide relief from acute and chronic pain (Mayo Clinic, 2024).

Other names
Descending pain modulatory systemDescending inhibitory pathwaysEndogenous analgesic systemCentral pain modulation
02

Mechanism of action

Enhancement of descending inhibitory control through the activation of opioid, adrenergic, or serotonergic receptors in the spinal cord and brainstem.

03

Biological functions

Pain modulationNociception regulationSensory processingEndogenous analgesia
04

Disease associations

Chronic painNeuropathic painFibromyalgiaHyperalgesia
05

Safety considerations

Respiratory depressionSedationPhysical dependenceToleranceSerotonin syndrome
06

Interacting drugs

Morphine

5 more in the full profile.

07

Biomarkers

Conditioned Pain Modulation (CPM)Quantitative Sensory Testing (QST)Functional MRI (fMRI) of the brainstem

Beyond the preview

Go deeper on Central analgesic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central analgesic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call